Loading clinical trials...
Loading clinical trials...
Clinical Study of Azacitidine Combined With Homoharringtonie Based Regimens in Acute Myeloid Leukemia
Conditions
Interventions
Homoharringtonine
Azacitidine
Locations
1
China
Department of Hematology, Zhongda Hospital, Medical School of Southeast University
Nanjing, China
Start Date
December 1, 2019
Primary Completion Date
September 1, 2022
Completion Date
December 30, 2022
Last Updated
September 8, 2022
NCT05564390
NCT03050268
NCT07320235
NCT06782542
NCT06439199
NCT05886049
Lead Sponsor
Ge Zheng
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions